Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature

IF 36.4 1区 医学 Q1 INFECTIOUS DISEASES
Gian Marco Berti, Elisabetta Manaresi, Gisella Vischini, Michele Provenzano, Valeria Corradetti, Maddalena Giannella, Cecilia Bonazzetti, Matteo Rinaldi, Benedetta Fabbrizio, Matteo Ravaioli, Giorgio Gallinella, Gaetano La Manna, Giorgia Comai
{"title":"Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature","authors":"Gian Marco Berti, Elisabetta Manaresi, Gisella Vischini, Michele Provenzano, Valeria Corradetti, Maddalena Giannella, Cecilia Bonazzetti, Matteo Rinaldi, Benedetta Fabbrizio, Matteo Ravaioli, Giorgio Gallinella, Gaetano La Manna, Giorgia Comai","doi":"10.1016/s1473-3099(24)00560-7","DOIUrl":null,"url":null,"abstract":"We report the case of a 34-year-old male recipient of an ABO-incompatible living donor kidney transplant who was repeatedly hospitalised for anaemia. Acute kidney injury in a patient with severe and recurrent anaemia related to parvovirus B19 infection was diagnosed through viral and histopathological analysis. In view of the patient's impaired immune response due to the immunosuppressive regimen, clinical stabilisation was reached by repeated intravenous immunoglobulin administration as a maintenance therapy in a prolonged course, although viral clearance did not occur. Review of the literature highlighted a variety of pathological renal lesions associated with parvovirus B19 infection, although epidemiological data on parvovirus B19 infection in kidney transplant recipients, standardised diagnostic and therapeutic protocols, and the prospect for specific antiviral therapy are still scarce. Increased awareness of clinical relevance of parvovirus B19 infection in patients who have had a kidney transplant should direct future efforts towards better consideration and comprehension of viral-induced pathogenesis, aimed at effective diagnosis and appropriate therapy.","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"16 1","pages":""},"PeriodicalIF":36.4000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s1473-3099(24)00560-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

We report the case of a 34-year-old male recipient of an ABO-incompatible living donor kidney transplant who was repeatedly hospitalised for anaemia. Acute kidney injury in a patient with severe and recurrent anaemia related to parvovirus B19 infection was diagnosed through viral and histopathological analysis. In view of the patient's impaired immune response due to the immunosuppressive regimen, clinical stabilisation was reached by repeated intravenous immunoglobulin administration as a maintenance therapy in a prolonged course, although viral clearance did not occur. Review of the literature highlighted a variety of pathological renal lesions associated with parvovirus B19 infection, although epidemiological data on parvovirus B19 infection in kidney transplant recipients, standardised diagnostic and therapeutic protocols, and the prospect for specific antiviral therapy are still scarce. Increased awareness of clinical relevance of parvovirus B19 infection in patients who have had a kidney transplant should direct future efforts towards better consideration and comprehension of viral-induced pathogenesis, aimed at effective diagnosis and appropriate therapy.
我们报告了一例 34 岁男性 ABO 不兼容活体肾移植受者因贫血反复住院的病例。通过病毒和组织病理学分析,诊断出患者的急性肾损伤与副病毒 B19 感染有关,并伴有严重的复发性贫血。鉴于免疫抑制方案导致患者免疫反应受损,虽然病毒没有被清除,但通过长期反复静脉注射免疫球蛋白作为维持疗法,患者的临床病情趋于稳定。尽管有关肾移植受者感染副病毒 B19 的流行病学数据、标准化诊断和治疗方案以及特异性抗病毒治疗的前景仍然匮乏,但文献综述强调了与副病毒 B19 感染相关的各种肾脏病变。随着人们对肾移植患者感染副病毒 B19 的临床相关性认识的提高,未来的努力方向应是更好地考虑和理解病毒引起的发病机制,从而进行有效的诊断和适当的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Lancet Infectious Diseases
Lancet Infectious Diseases 医学-传染病学
CiteScore
60.90
自引率
0.70%
发文量
1064
审稿时长
6-12 weeks
期刊介绍: The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.The infectious diseases journal aims to be a world-leading publication, featuring original research that advocates change or sheds light on clinical practices related to infectious diseases. The journal prioritizes articles with the potential to impact clinical practice or influence perspectives. Content covers a wide range of topics, including anti-infective therapy and immunization, bacterial, viral, fungal, and parasitic infections, emerging infectious diseases, HIV/AIDS, malaria, tuberculosis, mycobacterial infections, infection control, infectious diseases epidemiology, neglected tropical diseases, and travel medicine. Informative reviews on any subject linked to infectious diseases and human health are also welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信